Product
Factor IX
Aliases
Factor IX (FIX)
3 clinical trials
2 indications
Indication
Hemophilia BIndication
Hemophilia AClinical trial
An Observational Post-authorization Long-term Follow-up Study to Characterize the Effectiveness and Safety of HEMGENIX® (Etranacogene Dezaparvovec) in Patients With Hemophilia BStatus: Recruiting, Estimated PCD: 2043-08-01
Clinical trial
Phase III, Open-label, Single-dose, Multi-center, Multinational Trial Investigating a Serotype 5 Adeno-associated Viral Vector Containing the Padua Variant of a Codon-optimized Human Factor IX Gene (AAV5-hFIXco-Padua, AMT-061) Administered to Adult Subjects With Severe or Moderately Severe Hemophilia BStatus: Active (not recruiting), Estimated PCD: 2021-09-22
Clinical trial
An in Vitro Pilot Study of the Role of Factor IX as an Alternative to Bypassing Agents in the Treatment of Breakthrough Bleeds in Patients With Hemophilia A and Inhibitors Treated With Emicizumab.Status: Recruiting, Estimated PCD: 2024-07-01